KT-220

N/A

Report date: 2025/01/26 17:42:28

Base Information

Drug NameKT-220
Drug Alias Nameatrial natriuretic peptides (Kalos)KT-220
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMitogen-activated protein kinase inhibitors
TargetsMitogen-activated protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of South Florida
China Registration ClassN/A

Develop Information

Active CompaniesKalos Therapeutics Inc
Inactive CompaniesUniversity Of South Florida
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A